Acrobiosystems Co.,Ltd. (SHE:301080)

China flag China · Delayed Price · Currency is CNY
45.00
+1.61 (3.71%)
At close: Mar 6, 2026
Market Cap7.53B +14.0%
Revenue (ttm)794.52M +33.6%
Net Income172.77M +58.6%
EPS1.03 +58.4%
Shares Out167.40M
PE Ratio43.73
Forward PE29.80
Dividend0.57 (1.27%)
Ex-Dividend Daten/a
Volume3,007,276
Average Volume3,748,623
Open43.30
Previous Close43.39
Day's Range43.22 - 45.06
52-Week Range26.00 - 71.49
Beta0.87
RSI31.91
Earnings DateApr 21, 2026

About Acrobiosystems

Acrobiosystems Co.,Ltd. engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and scientific research institutions. The company has a collaboration with Diagnostic Biochips Inc for neurological drug discovery and commercialization. The company was founded in 2010 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301080
Full Company Profile

Financial Performance

In 2024, Acrobiosystems's revenue was 645.02 million, an increase of 18.65% compared to the previous year's 543.65 million. Earnings were 123.83 million, a decrease of -19.38%.

Financial Statements